TrialRMD open2025

Measurement properties of disease activity instruments in peripheral spondyloarthritis: a post-hoc analysis of the CRESPA trial.

Clementina López-Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.